Why the study?
How do different types of heart failure and beta-blocker treatments affect cardiac beta 1- and beta 2-adrenoceptor density and distribution?
Population
Patients with different kinds of heart failure
Design
Review
Authors
Loading...
Etiology-specific adrenoceptor changes may inform tailored beta-blocker strategies; extends receptor observations but leaves clinical translation open.
How do different types of heart failure and beta-blocker treatments affect cardiac beta 1- and beta 2-adrenoceptor density and distribution?
Different etiologies of heart failure differentially affect beta-adrenoceptor subtypes, and beta-blocker therapy induces subtype-selective receptor up-regulation, potentially explaining its beneficial effects.
Brodde et al. (1989) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: